Subsequently, researchers identified LDAM in the brain tissues of AD patients, particularly in those with the APOE4/4 genotype, and proposed that the formation of LDAM is closely associated with acyl-CoA synthetase long-chain family member 1 (ACSL1) expression in microglia. The gene discussed is ACSL1; the disease is Alzheimer disease.